¡Ø Ãß¼® ¿¬ÈÞ ÈÞ¹«¾È³» : 2024³â 9¿ù 16ÀÏ(¿ù) ~ 2024³â 9¿ù 18ÀÏ(¼ö)

½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1498721

À¯·´ÀÇ µðÁöÅÐ Ä¡·á ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÆǸŠä³Îº°, ±¹°¡º° ºÐ¼® ¹× ¿¹Ãø(2023-2033³â)

Europe Digital Therapeutics Market: Focus on Product Type, Application, Sales Channel, and Country - Analysis and Forecast, 2023-2033

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: BIS Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 1-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À¯·´ÀÇ µðÁöÅÐ Ä¡·á ½ÃÀå ±Ô¸ð´Â 2023³â 16¾ï 8,000¸¸ ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È CAGR 23.54%·Î ÃßÀÌÇÏ°í, 2033³â¿¡´Â 139¾ï 1,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº µðÁöÅÐ Ä¡·áÀÇ ÀüÅëÀûÀÎ Ä¡·á¹ýÀ» ´É°¡ÇÏ´Â ÀÌÁ¡, Áö¼ÓÀûÀÎ ±â¼ú Áøº¸, ºñ¿ë È¿À²ÀûÀÎ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÃßÁøµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2023-2033³â
2023³â Æò°¡ 16¾ï 8,000¸¸ ´Þ·¯
2033³â ¿¹Ãø 139¾ï 1,000¸¸ ´Þ·¯
CAGR 23.54%

µðÁöÅÐ Ä¡·áÀÇ Ã¤¿ëÀº ȯÀÚ °á°ú °³¼± ¹× °³ÀÎÈ­µÈ ÀÇ·á ¼Ö·ç¼Ç°ú °°Àº ±âÁ¸ Ä¡·á¸¦ ´É°¡ÇÏ´Â ¿©·¯ ÀåÁ¡À¸·Î ÀÎÇØ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. AI¿Í ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀ» Æ÷ÇÔÇÑ Áö¼ÓÀûÀÎ ±â¼úÀÇ ¹ßÀüÀº ÀÌ·¯ÇÑ Ä¡·á¹ýÀÇ È¿´É°ú Á¢±Ù¼ºÀ» Çâ»ó½ÃÅ°°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½Â°ú ºñ¿ë È¿°úÀûÀÎ °Ç°­ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡ÇÏ°í ÀÖ½À´Ï´Ù. Áö¿ø ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©¿Í µðÁöÅÐ °Ç°­¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡µµ ½ÃÀåÀ» ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ÁÖ¿ä ±â¾÷Àº ½ÃÀå¿¡¼­ÀÇ ÁöÀ§¸¦ °­È­Çϱâ À§ÇØ Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß°ú Àü·«Àû Á¦ÈÞ¿¡ ÁÖ·ÂÇÏ°í ÀÖÀ¸¸ç, À¯·´ÀÇ µðÁöÅÐ ¼¼¶óǶƽ½º ½ÃÀå ÀüüÀÇ ¼ºÀåÀ» °ßÀÎÇÏ°í ÀÖ½À´Ï´Ù.

½ÃÀå ºÐ·ù:

ºÎ¹® 1: Á¦Ç° À¯Çüº°

  • ¼ÒÇÁÆ®¿þ¾î
  • µð¹ÙÀ̽º

ºÎ¹® 2: ¿ëµµº°

  • Ä¡·á/ȯÀÚ Äɾî
  • ¿¹¹æ

ºÎ¹® 3: ÆǸŠä³Îº°

  • B2B
  • B2C

ºÎ¹® 4: ±¹°¡º°

  • ¿µ±¹
  • µ¶ÀÏ
  • ÇÁ¶û½º
  • ÀÌÅ»¸®¾Æ
  • ½ºÆäÀÎ
  • ±âŸ

º» º¸°í¼­¿¡¼­´Â À¯·´ÀÇ µðÁöÅÐ ¼¼¶óǶƽ½º ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ¾÷°è µ¿Çâ, ±â¼ú¡¤Æ¯Çã µ¿Çâ, ¹ý±ÔÁ¦ ȯ°æ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, ½ÃÀå ±Ô¸ð ÃßÀÌ¿Í ¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå ½ÃÀå

  • µ¿Çâ : ÇöÀç ¹× ¹Ì·¡ÀÇ ¿µÇâ Æò°¡
    • Æ®·»µå 1: Ä¡·á ¿µ¿ªÀ» ³ÑÀº È®´ë
    • Æ®·»µå 2: ÀÇ·á ¿¡ÄڽýºÅÛ°úÀÇ ÅëÇÕ
    • Æ®·»µå 3: µðÁöÅÐ Ä¡·á¿¡ ÀÇÇÑ AI¿Í ¸Ó½Å·¯´×(ML)ÀÇ È°¿ë
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÀÚ±Ý Á¶´Þ È°µ¿
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • ƯÇ㠺м®

Á¦2Àå µðÁöÅÐ Ä¡·á ½ÃÀå : Áö¿ªº°

  • Áö¿ªº° °³¿ä
  • À¯·´
    • Áö¿ª °³¿ä
    • ½ÃÀ强ÀåÃßÁøÀÎÀÚ
    • ½ÃÀåÀÇ °úÁ¦
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ

Á¦3Àå ½ÃÀå : °æÀï º¥Ä¡¸¶Å·¡¤±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ´ÙÀ½ ÇÁ·ÐƼ¾î
  • °æÀï ºÐ¼®
  • ¼¼°èÀÇ »ýÅ°è: °³¿ä
  • Áö¿ª Æò°¡
    • Cara Care
    • Kaia Health

Á¦4Àå Á¶»ç ¹æ¹ý

JHS 24.06.28

Introduction to Europe Digital Therapeutics Market

The Europe digital therapeutics market is projected to reach $13.91 billion by 2033 from $1.68 billion in 2023, growing at a CAGR of 23.54% during the forecast period 2023-2033. The growth of the digital therapeutics market is propelled by the advantages digital therapeutics provide over conventional treatments, ongoing technological advancements, and a rising demand for cost-effective healthcare solutions.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1.68 Billion
2033 Forecast$13.91 Billion
CAGR23.54%

Market Introduction

The Europe digital therapeutics market is experiencing significant growth driven by several key factors. The adoption of digital therapeutics is increasing due to their multiple advantages over traditional treatments, such as improved patient outcomes and personalized healthcare solutions. Continuous technological advancements, including the integration of AI and machine learning, are enhancing the effectiveness and accessibility of these therapies. Additionally, the rising prevalence of chronic diseases and the increasing demand for cost-effective healthcare solutions are fueling market expansion. Supportive regulatory frameworks and growing investments in digital health are further boosting the market. Major players in the region are focusing on innovative product development and strategic partnerships to strengthen their market position, driving the overall growth of the Europe digital therapeutics market.

Market Segmentation:

Segmentation 1: by Product Type

  • Software
  • Devices

Segmentation 2: by Application

  • Treatment/Patient Care-Related Applications
  • Preventive Applications

Segmentation 3: by Sales Channel

  • Business-to-Business
  • Business-to-Customer

Segmentation 4: by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Rest-of-Europe

How does Digital Therapeutic Report provide value to this organization

Product/Innovation Strategy: The Europe digital therapeutics market has been extensively segmented based on various categories, such as product type, application, and sales channel. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The digital therapeutics market has numerous established players with product portfolios that address an extensive range of conditions. Key players in the Europe digital therapeutics market analyzed and profiled in the study involve established players offering various digital solutions for treatment/patient care-related and preventive applications.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names in the market include:

  • Cara Care
  • Kaia Health

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Trend 1: Expansion across Therapeutic Areas
    • 1.1.2 Trend 2: Integration with the Healthcare Ecosystem
    • 1.1.3 Trend 3: Utilization of Artificial Intelligence (AI) and Machine Learning (ML) with Digital Therapeutics
  • 1.2 Value Chain Analysis
  • 1.3 Funding Activities
  • 1.4 Regulatory Framework
  • 1.5 Patent Analysis

2 Digital Therapeutics Market (By Region)

  • 2.1 Regional Summary
  • 2.2 Europe
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 U.K.
    • 2.2.5 Germany
    • 2.2.6 France
    • 2.2.7 Italy
    • 2.2.8 Spain
    • 2.2.9 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Competitive Analysis
  • 3.3 Global Ecosystem Glimpse
  • 3.4 Geographic Assessment
    • 3.4.1 Cara Care
      • 3.4.1.1 Overview
      • 3.4.1.2 Top Products/Product Portfolio
      • 3.4.1.3 Top Competitors
      • 3.4.1.4 Target Customers
      • 3.4.1.5 Key Personnel
      • 3.4.1.6 Analyst View
    • 3.4.2 Kaia Health
      • 3.4.2.1 Overview
      • 3.4.2.2 Top Products/Product Portfolio
      • 3.4.2.3 Key Developments
      • 3.4.2.4 Top Competitors
      • 3.4.2.5 Target Customers
      • 3.4.2.6 Key Personnel
      • 3.4.2.7 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦